Search Results - V. E. Shevchenko

Refine Results
  1. 1

    The proteomics in prostate cancer biomarker discovery by V. E. Shevchenko, A. V. Olenich, N. E. Olenich

    Published 2015-06-01

    Prostate cancer (PC) represents the second most frequent type of tumor in men worldwide. Proteomics represents a promising approach for the discovery of new biomarkers able to improve the management of PC patients. Markers more specific and sensitive than prostate-specific antigen are needed for PC...

    Full description

    Get full text
    Article
  2. 2

    Proteomic studies searching for breast cancer markers: а review of literature by M. A. Taipov, Z. N. Nikiforova, V. E. Shevchenko

    Published 2015-07-01

    Breast malignancies hold the lead in the pattern of cancers among women worldwide. Currently used methods for the instrumental diagnosis of breast cancer (BC) and their related diagnostic procedures are not sophisticated. The common constraint of instrumental techniques is the ambiguity of resultы i...

    Full description

    Get full text
    Article
  3. 3

    Transcriptomic analysis of neural stem and progenitor cells in comparison with glioblastoma stem cells by V. E. Shevchenko, N. E.  Arnotskaya, T.  I. Kushnir, A. S. Bryukhovetskiy

    Published 2023-12-01

    Introduction. There is currently no effective therapy for the treatment of glioblastoma. This is partly explained by the high degree of intra- and intertumor heterogeneity of GB, the source of which is believed to be glioblastoma stem cells (GSC). The question of the origin of GSC, which is importan...

    Full description

    Get full text
    Article
  4. 4

    The therapeutic potential of curcumin for the treatment of glioblastoma multiforme by T. I. Kushnir, N. E. Arnotskaya, I. A. Kudryavtsev, V. E. Shevchenko

    Published 2020-03-01

    Glioblastoma multiforme (GBM), a grade IV astrocytoma, is the most common and deadly type of primary malignant brain tumor, with a patien’s median survival rate ranging from 12 to 15 months. Over the last fifteen years, the treatment for GBM has included maximal safe surgical resection with combinat...

    Full description

    Get full text
    Article
  5. 5

    Ferroptosis determinants – potential predictors and therapeutic targets for acute myeloid leukemia by V. E. Shevchenko, T. I. Kushnir, M. V. Gudkova, N. E. Arnotskaya

    Published 2025-06-01

    Ferroptosis (FP) is a type of non-apoptotic programmed cell death associated with iron-dependent lipid peroxidation. FP is characterized by a decrease in the activity of glutathione peroxidase 4, which is necessary for the suppression of lipid peroxidation, accumulation of redox-active iron and oxid...

    Full description

    Get full text
    Article
  6. 6

    Study of interaction between extracellular matrix proteins and receptors of CD133+ stem cells and CD133– differentiated glioma cells by V. E. Shevchenko, I. S. Bryukhovetskiy, E. A. Savchenko, N. E. Arnotskaya

    Published 2019-04-01

    Background. Treatment of glioblastoma multiforme remains little effective due to the rapidly developing recurrence of the tumor, due to its high tumorigenic potential, resistance to chemoradiation therapy and increased dissemination of glioma stem cells (GSC). Molecular mechanisms of these cell inte...

    Full description

    Get full text
    Article
  7. 7

    Wnt-signaling pathway in pathogenesis of glioblastoma multiforme by Yu. D. Vasilets, N. E. Arnotskaya, I. A. Kudryavtsev, V. E. Shevchenko

    Published 2019-01-01

    The Wnt-signaling pathway regulates various biological processes, such as embryonic development, self-renewal, proliferation, differentiation and migration of stem cells. The Wnt-signaling is involved in tumor progression by aberrant activation in stem-like cells, called cancer stem cells, in differ...

    Full description

    Get full text
    Article
  8. 8

    Molecular markers of endometrial cancer (review of literature) by N. E. Levchenko, K. P. Laktionov, M. A. Taipov, M. S. Titova, V. E. Shevchenko

    Published 2014-07-01

    Currently, basic research in oncology focused on finding new potential markers of metastatic activity of tumor cells and rational approaches to cancer therapy. Constant search for biomarkers of endometrial cancer with high sensitivity and specificity, is a promising direction in medicine. Identifica...

    Full description

    Get full text
    Article
  9. 9

    Tumor stem cells from glioblastoma multiforme by Z. N. Nikiforova, I. A. Kudryavtsev, N. E. Arnotskaya, I. S. Bryukhovetskiy, V. E. Shevchenko

    Published 2016-06-01

    Glioblastoma multiforme, a World Health Organization grade IV malignant glioma, is the most common and lethal primary brain tumor with the median survival of approximately 15–25 months after treatment. Glioblastoma multiforme has been shown to be resistant to radiotherapy and chemotherapy and invari...

    Full description

    Get full text
    Article
  10. 10

    MicroRNA MiR-21 and MiR-155 are new markers for breast cancer by M. A. Taipov, Z. N. Nikiphorova, K. P. Laktionov, N. E. Levchenko, V. E. Shevchenko

    Published 2014-07-01

    In the cell there is a large class of regulatory molecules referred to as microRNA. Many investigators regard microRNA Mir and Mir-155 as new potential prognostic markers and targets for goal-oriented therapy for breast cancer (BC) these days. MiR-21 and MiR-155 have been found to regulate the metas...

    Full description

    Get full text
    Article
  11. 11

    Proteomics in the diagnosis of ovarian cancer by V. E. Shevchenko, N. E. Arnotskaya, D. E. Makarov, N. R. Pogosyan, K. I. Zhordania

    Published 2014-07-01

    Proteomics has recently found wide application to account for the molecular mechanisms of cancer and to search for biomarkers that may be used to diagnose and/or predict the development of the disease. The paper briefly reviews proteomic studies to detect ovarian cancer biomarkers, by taking into ac...

    Full description

    Get full text
    Article
  12. 12

    Role of a cyclooxygenase-2 cascade in breast cancer cell dissemination by M. A. Taipov, I. A. Kudryavtsev, K. P. Laktionov, N. E. Levchenko, V. E. Shevchenko

    Published 2014-07-01

    Current therapeutic approaches based on a study of the genetic portrait of a tumor individualize treatment policy to a greater extent, which cre- ates real prospects for the increasing number of patients to recover. Experimental and clinical evidence suggest that the increased expression of the COX-...

    Full description

    Get full text
    Article
  13. 13

    The transforming growth factor beta-1 in the oncogenesis of human lung adenocarcinoma by V. E. Shevchenko, I. S. Bryukhovetskiy, Z. N. Nikiforova, S. V. Kovalev, I. A. Kudryavtsev, N. E. Arnotskaya

    Published 2017-10-01

    Background. The transforming growth factor beta 1 (TGF-β1) is one of the most important tissue factors secreted by the development of epithelial tumors. Increased expression of TGF-β1 in lung tumors promotes cancer cells survival enhancing their growth, migration, invasion, angiogenesis, immune syst...

    Full description

    Get full text
    Article
  14. 14

    Identification of proteomic markers for metastasis of ovarian cancer by V. E. Shevchenko, D. E. Makarov, S. V. Kovalev, N. E. Arnotskaya, N. R. Pogosyan, K. I. Zhordania

    Published 2014-08-01

    The proteome of ascites and pleural fluids (AF and PF) was mapped in patients with ovarian cancer (OC). 240 and 190 proteins were identi- fied with a high degree of assurance in A F and PF, respectively . The major portion w as extracellular and membrane proteins, whi ch ac- counted for 45 and 49 %...

    Full description

    Get full text
    Article
  15. 15

    The effect of hypoxia on the secretome of human glioblastoma multiforme cells by T. I. Kushnir, N. E. Arnotskaya, I. A. Kudryavtsev, A. A. Mitrofanov, A. K. Bekyashev, V. E. Shevchenko

    Published 2021-05-01

    Background. Glioblastoma multiforme (GBM) develops in the hypoxic microenvironment, which plays an important role in the pathogenesis of the disease and is closely associated with tumor growth, development and poor prognosis. Hypoxia increases the resistance of tumor cells (TC) to radiation therapy...

    Full description

    Get full text
    Article
  16. 16

    Identification of predictive markers in the cerebrospinal fluid of patients with glioblastoma by N. E. Arnotskaya, T. I. Kushnir, I. A. Kudryavtsev, A. A. Mitrofanov, A. Kh. Bekyashev, V. E. Shevchenko

    Published 2023-07-01

    Introduction. Glioblastoma  (GB) is not yet curable despite recent advances in the treatment of other malignant solid tumors. The management of GB is based solely on histopathological features, imaging of the tumor and its genomic analysis (somatic mutations in the isocitrate dehydrogenase genes, me...

    Full description

    Get full text
    Article
  17. 17

    Discovery of potential ovarian cancer biomarkers using low molecular weight blood plasma proteome profiling by mass spectrometry by V. E. Shevchenko, N. E. Arnotskaya, E. V. Ogorodnikova, N. R. Pogosyan, A. N. Gritsay, K. I. Zhordania

    Published 2014-07-01

    At present, there is no screening test for the early detecting and monitoring of ovarian cancer, one of the most lethal form of gynaecological malig- nancy in the worldwide. In this study, the new methodology for the search of tumor markers of ovarian cancer, involving profiling the low-molec- ular...

    Full description

    Get full text
    Article
  18. 18

    Molecular determinants of transforming growth factor beta-1 action on human glioblastoma cells by V. E. Shevchenko, S. V. Kovalev, N. E. Arnotskaya, Z. N. Nikiforova, I. A. Kudryavtsev, E. A. Savchenko, I. S. Bryukhovetskiy

    Published 2016-06-01

    Background. Increased expression of transforming growth factor beta-1 (TGF-β1) in malignant brain tumors promotes cancer cells survival enhancing their growth, migration, invasion, angiogenesis, immune system suppression.Objective is to study molecular mechanisms of TGF-β1 action on U87 human gliobl...

    Full description

    Get full text
    Article
  19. 19

    Mapping of proteomic lysate of a MCF-7 cancer cell line for the identification of potential markers for breast cancer by V. E. Shevchenko, M. A. Taipov, S. V. Kovalev, N. E. Arnotskaya, O. M. Pavlova, I. A. Kudryavtsev, Z. N. Nikiforova

    Published 2014-07-01

    Mass spectrometric mapping of proteomic lysate of a MCF-7 cancer cell line was carried out, which identified 153 proteins having molecular weights of 5000 to 630000 Da, a high proportion of which was cytoplasmic and nuclear proteins. The latter accounted for 60 % of their total number whereas the pr...

    Full description

    Get full text
    Article
  20. 20

    Analysis of proteins associated with the expression of cyclooxygenase-2 and the biosynthesis of PGE2 in breast cancer cells with different metastatic potential by V. E. Shevchenko, M. A. Taipov, S. V. Kovalev, N. E. Arnotskaya, O. M. Pavlova, I. A. Kudryavtsev, Z. N. Nikiforova

    Published 2014-07-01

    The proteome of lysates of the breast tumor cell lines MCF-7, BT-474, and ZR-75-1 was mapped, resulting in the sequence of 340 proteins. The proteins associated with the biosynthesis of PGE2 and with the regulation of cyclooxygenase-2 expression were identified and their relative expression levels w...

    Full description

    Get full text
    Article